Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries

BACKGROUND AND OBJECTIVES: COVID‐19 convalescent plasma (CCP) has been used, predominantly in high‐income countries (HICs) to treat COVID‐19; available data suggest the safety and efficacy of use. We sought to develop guidance for procurement and use of CCP, particularly in low‐ and middle‐income co...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Vox Sang
Päätekijät: Bloch, Evan M., Goel, Ruchika, Wendel, Silvano, Burnouf, Thierry, Al‐Riyami, Arwa Z., Ang, Ai Leen, DeAngelis, Vincenzo, Dumont, Larry J., Land, Kevin, Lee, Cheuk‐kwong, Oreh, Adaeze, Patidar, Gopal, Spitalnik, Steven L., Vermeulen, Marion, Hindawi, Salwa, Van den Berg, Karin, Tiberghien, Pierre, Vrielink, Hans, Young, Pampee, Devine, Dana, So – Osman, Cynthia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Original Papers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7323328/
https://ncbi.nlm.nih.gov/pubmed/32533868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vox.12970
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia